{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:40:30Z","timestamp":1790520030607,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2007,10,10]]},"DOI":"10.1007\/s10096-007-0370-9","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T09:20:22Z","timestamp":1185873622000},"page":"777-783","source":"Crossref","is-referenced-by-count":34,"title":["In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units"],"prefix":"10.1007","volume":"26","author":[{"given":"Y.","family":"Glupczynski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-D.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Berhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delm\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ieven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pierard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rodriguez-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Struelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vaneldere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,1]]},"reference":[{"issue":"Suppl 5","key":"370_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-198500295-00011","volume":"29","author":"B Slocombe","year":"1985","unstructured":"Slocombe B, Cooper CE, Griffin KE, White AR (1985) Temocillin: in vitro antibacterial activity. Drugs 29(Suppl 5):49\u201356","journal-title":"Drugs"},{"issue":"Suppl. 5","key":"370_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198500295-00003","volume":"29","author":"H Landuyt Van","year":"1985","unstructured":"Van Landuyt H, Boelaert J, Piot P, Verbist L (1985) In vitro activity of temocillin against clinical isolates. Drugs 29(Suppl 5):1\u20138","journal-title":"Drugs"},{"key":"370_CR3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/26.6.735","volume":"26","author":"RC Spencer","year":"1990","unstructured":"Spencer RC (1990) Temocillin. J Antimicrob Chemother 26:735\u2013737","journal-title":"J Antimicrob Chemother"},{"key":"370_CR4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/jac\/29.3.341","volume":"29","author":"RF Taylor","year":"1992","unstructured":"Taylor RF, Gaya H, Hodson ME (1992) Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia. J Antimicrob Chemother 29:341\u2013344","journal-title":"J Antimicrob Chemother"},{"key":"370_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcf.2005.12.005","volume":"5","author":"A Lekkas","year":"2006","unstructured":"Lekkas A, Gyi KM, Hodson ME (2006) Temocillin in the treatment of Burkholderia cepacia infections in cystic fibrosis. J Cyst Fibros 5:121\u2013124","journal-title":"J Cyst Fibros"},{"key":"370_CR6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1179\/acb.2001.053","volume":"56","author":"R Vanhoof","year":"2001","unstructured":"Vanhoof R, Berhin C, Carpentier M, et al (2001) Comparative in vitro activity of temocillin and other antimicrobial agents against Enterobacteriaceae isolated from patients admitted to five Belgian hospitals. Acta Clin Belg 56:354\u2013359","journal-title":"Acta Clin Belg"},{"key":"370_CR7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/jac\/dkl046","volume":"57","author":"H Rodriguez-Villalobos","year":"2006","unstructured":"Rodriguez-Villalobos H, Malaviolle V, Frankard J, de Mendon\u00e7a R, Nonhoff C, Struelens MJ (2006) In vitro activity of temocillin against extended spectrum \u03b2-lactamase-producing Escherichia coli. J Antimicrob Chemother 57:771\u2013774","journal-title":"J Antimicrob Chemother"},{"key":"370_CR8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jac\/dkl043","volume":"57","author":"DM Livermore","year":"2006","unstructured":"Livermore DM, Hope R, Fagan EJ, Warner M, Woodford N, Potz N (2006) Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England. J Antimicrob Chemother 57:1012\u20131014","journal-title":"J Antimicrob Chemother"},{"key":"370_CR9","unstructured":"Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing. Approved standard MS100-S16. CLSI, Wayne, PA, USA"},{"key":"370_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF02148656","volume":"4","author":"PC Fuchs","year":"1985","unstructured":"Fuchs PC, Barry AL, Thornsberry C, Jones RN (1985) Interpretive criteria for temocillin disk diffusion susceptibility testing. Eur J Clin Microbiol 4:30\u201333","journal-title":"Eur J Clin Microbiol"},{"key":"370_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jac\/dkh274","volume":"54","author":"E St\u00fcrenburg","year":"2004","unstructured":"St\u00fcrenburg E, Sobottka I, Noor D, Laufs R, Mack D (2004) Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum \u03b2-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother 54:134\u2013138","journal-title":"J Antimicrob Chemother"},{"key":"370_CR12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/dkg415","volume":"52","author":"Y Gheldre De","year":"2003","unstructured":"De Gheldre Y, Avesani V, Berhin C, Delmee M, Glupczynski Y (2003) Evaluation of Oxoid combination discs for detection of extended-spectrum \u03b2-lactamases. J Antimicrob Chemother 52:591\u2013597","journal-title":"J Antimicrob Chemother"},{"key":"370_CR13","unstructured":"De Gheldre Y, Glupczynski Y, Berhin C et al (2004) Epidemiology of Enterobacter aerogenes in Belgium: results of a multicentre survey. In: Abstracts of the 14th European Congress of Clinical Microbiology and Infectious Diseases. Abstract no. P-1122. Clin Microbiol Infect 10(Suppl 3):305 (abstract)"},{"key":"370_CR14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/JCM.39.3.889-896.2001","volume":"39","author":"Y De Gheldre","year":"2001","unstructured":"De Gheldre Y, Struelens MJ, Glupczynski Y, et al (2001) National epidemic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol 39:889\u2013896","journal-title":"J Clin Microbiol"},{"key":"370_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1179\/acb.2001.044","volume":"56","author":"Y Glupczynski","year":"2001","unstructured":"Glupczynski Y, Delm\u00e9e M, Goossens H, Struelens MJ (2001) Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units in Belgian hospitals between 1996 and 1999. Acta Clin Belg 56:297\u2013306","journal-title":"Acta Clin Belg"},{"key":"370_CR16","unstructured":"Ieven M, Delmee M, De Mol P et al (2006) Eight years of Belgian MYSTIC surveillance: 1998\u20132005. In: Abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases, Nice, France, April 2006, Abstract no. P-1387"},{"key":"370_CR17","doi-asserted-by":"crossref","unstructured":"Rodriguez-Villalobos H, Malaviolle V, Frankard J et al (2005) Emergence of CTX-M extended-spectrum \u03b2-lactamase-producing Escherichia coli in Belgium. Euro-surveillance Weekly 10:63. Available online: ( http:\/\/www.eurosurveillance.org\/ew\/2005\/050224.asp#3 )","DOI":"10.2807\/esw.10.08.02650-en"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-007-0370-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0370-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:30:28Z","timestamp":1559107828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-007-0370-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,10,10]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0370-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}